Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Clinical trial NCT00243685 · COMPLETED

Trial details

NCT number: NCT00243685
Sponsor: Pierian Biosciences
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Sarcoma, Soft Tissue

Start date: 2006-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.